CVRx, Inc.
NASDAQ:CVRXMedical - Devices
+$0.11 today
- Market cap
- $69.79M
- Beta
- 0.77
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$2.00
Volume 0.37M
Average 0.30M
Returns on capital
CVRx, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-135.6%
avg -47.4%
ROIC
-56.0%
avg -38.4%
ROA
-50.9%
avg -37.9%
Analysis
ROA is currently the strongest return metric at -50.9% versus its period average of -37.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Kevin Hykes | President, Chief Executive Officer & Director | USD 2.64M | 60 | 284.24K | 1.07% |
Philip Adamson | Chief Medical Officer | USD 1.1M | 65 | — | — |
Robert Allen John | Chief Revenue Officer | USD 1.05M | 52 | 86.04K | 0.32% |
Paul Verrastro | Chief Marketing & Strategy Officer | USD 598.97K | 63 | 60.55K | 0.23% |
Jared Oasheim | Chief Financial Officer | USD 517.27K | 43 | 96.70K | 0.36% |
Bonnie Handke | Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics | — | — | — | — |
Brent Binkowski | Chief Operating Officer | — | 57 | 56.51K | 0.21% |
Gregory Morrison | Chief Human Resources Officer | — | 62 | 0 | <0.01% |
Compensation is shown in the reported currency; data updated Aug 29, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 13, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
3
$376,809.04
Sells
11
$444,645.54
Net Transaction Value
−$67,836.50
Net selling
Most Active
JOHNSON & JOHNSON
5 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Aug 13, 26Aug 13, 2026 | Binkowski Brent Direct | Buy | $76.4K$76,432.18 |
| Aug 12, 26Aug 12, 2026 | Binkowski Brent Direct | Sell | $3.3K$3,338.21 |
| Mar 2, 26Mar 2, 2026 | OASHEIM JARED Direct | Sell | $13.8K$13,781.44 |
| Mar 2, 26Mar 2, 2026 | Adamson Philip B. Direct | Sell | $10K$9,973.21 |
| Mar 2, 26Mar 2, 2026 | John Robert Allen Direct | Sell | $31.3K$31,325.51 |
| Mar 2, 26Mar 2, 2026 | VERRASTRO PAUL Direct | Sell | $10.1K$10,146.30 |
| Mar 2, 26Mar 2, 2026 | Hykes Kevin Direct | Sell | $61.3K$61,348.66 |
| Feb 20, 26Feb 20, 2026 | Jain Mudit K. Indirect | Buy | $297.6K$297,591.84 |
| Feb 18, 26Feb 18, 2026 | Jain Mudit K. Direct | Buy | $2.8K$2,785.02 |
| Nov 26, 25Nov 26, 2025 | JOHNSON & JOHNSON Indirect | Sell | $63.6K$63,560.11 |
1–10 of 14
Summary
Insiders reported 3 buys worth $376,809.04 and 11 sells worth $444,645.54 over the last 12 months. That adds up to net selling of $67,836.50. JOHNSON & JOHNSON was the most active insider with 5 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +36.1% | +16.8% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at +36.1% over three years. Forward estimates point to Revenue at +16.8% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does CVRx, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about CVRX's management, answered from reported figures.
Who manages CVRX?
CVRx, Inc. (CVRX) lists 8 active executives. The top listed executive is Kevin Hykes, President, Chief Executive Officer & Director.
Are CVRX insiders buying or selling?
Recent insider activity shows net buying of $29.53M.
Continue the stock analysis
Jump to another research area for this company.